Case Report
Accepted on 17 Feb 2026
Case Report: Periungual Xeligekimab Injection for Refractory Acrodermatitis Continua of Hallopeau
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Case Report
Accepted on 17 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Review
Accepted on 17 Feb 2026
in Oncology Reviews: Reviews
Review
Accepted on 17 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Mini Review
Accepted on 17 Feb 2026
in Mucosal Immunity
Opinion
Accepted on 17 Feb 2026
in Avian Physiology
Brief Research Report
Accepted on 17 Feb 2026
in Memory
Original Research
Accepted on 17 Feb 2026
in Smart Technologies and Cities
Original Research
Accepted on 17 Feb 2026
in Educational Psychology
Original Research
Accepted on 17 Feb 2026
in Public Mental Health
Original Research
Accepted on 17 Feb 2026
in Sport Psychology
Review
Accepted on 17 Feb 2026
in Neurocritical and Neurohospitalist Care
Original Research
Accepted on 17 Feb 2026
in Plant Abiotic Stress
Hypothesis and Theory
Accepted on 17 Feb 2026
in Reproductive and Mating Physiology
Editorial
Accepted on 17 Feb 2026
in Systems Endocrinology
Systematic Review
Accepted on 17 Feb 2026
in Molecular Innate Immunity
Original Research
Accepted on 17 Feb 2026
in Primary Immunodeficiencies